Alumis Inc. (ALMS), a promising player in the biotechnology sector, is capturing the attention of investors with its significant potential upside of 262.60%. The company is dedicated to developing innovative..
AppLovin Corporation (NASDAQ: APP), a stalwart in the communication services sector, is capturing investor attention with its compelling market positioning and robust growth metrics. Specializing in the advertising agencies industry,..
Abeona Therapeutics Inc. (NASDAQ: ABEO), a prominent player in the biotechnology sector, is attracting significant investor interest due to its promising potential upside. With a market capitalization of $253.32 million,..
Nyxoah SA (NYSE: NYXH), a Belgium-based medical technology firm specializing in innovative solutions for obstructive sleep apnea (OSA), is catching the attention of investors with its potential upside. As of..
Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology firm, is catching the attention of investors with its innovative genetic medicine platform and promising upside potential. Headquartered in Hayward, California, Benitec..
Zhengye Biotechnology Holding Limited (ZYBT) has captured the attention of investors, particularly those interested in the healthcare sector focused on veterinary vaccines. Despite its relatively small market capitalization of $102.37..
For investors seeking opportunities in the technology sector, Sprout Social, Inc (NASDAQ: SPT) presents a compelling case with its innovative social media management solutions and a notable potential upside of..
Cytek Biosciences, Inc. (NASDAQ: CTKB), headquartered in Fremont, California, is making waves in the healthcare sector with its advanced cell analysis solutions. Specializing in medical devices, Cytek is at the..
Alpha Teknova, Inc. (NASDAQ: TKNO), a burgeoning player in the healthcare sector, has captured investor attention with its significant potential upside of 124.22%. Specializing in the production of essential reagents..
Outset Medical, Inc. (OM) is capturing the attention of investors with its promise of a remarkable 184% potential upside, according to analyst ratings. A key player in the healthcare sector,..
Marti Technologies, Inc. (NASDAQ: MRT) is making waves in the tech sector with a compelling growth narrative that has caught the attention of investors seeking significant upside potential. With a..
Fair Isaac Corporation (NYSE: FICO), a cornerstone in the technology sector, is renowned for its analytics software that influences decision-making processes across the globe. With a market capitalization of $42.15..
TruBridge, Inc. (NASDAQ: TBRG), a prominent player in the healthcare information services sector, presents an intriguing opportunity for investors seeking exposure to a niche segment of the healthcare industry. With..
Arcturus Therapeutics Holdings Inc. (ARCT), a biotechnology firm at the forefront of mRNA-based therapies and vaccines, is currently capturing investor attention with an astonishing projected upside of 383.22%. This expectation..
Quantum-Si Incorporated (NASDAQ: QSI) is capturing the attention of investors with its pioneering technologies in the healthcare sector. As a medical devices company based in the United States, Quantum-Si is..
Aura Biosciences, Inc. (NASDAQ: AURA) is capturing investor attention with its promising clinical-stage advancements in the biotechnology sector. Specializing in precision therapies for solid tumors, Aura’s innovative approach using virus-like..
Cartesian Therapeutics, Inc. (NASDAQ: RNAC), a clinical-stage biotechnology company, is gaining significant attention from investors due to its promising product pipeline and potential for substantial stock price appreciation. Headquartered in..
UroGen Pharma Ltd. (NASDAQ: URGN) stands at an intriguing crossroads for investors, particularly those focused on the biotechnology sector. With a market capitalization of $1.18 billion, this Princeton, New Jersey-based..
Gossamer Bio, Inc. (NASDAQ: GOSS), a clinical-stage biopharmaceutical company based in San Diego, California, has captured the attention of investors with its promising pipeline and significant potential upside. Specializing in..
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is a biopharmaceutical company making waves in the healthcare sector with its focus on developing cutting-edge treatments for gastrointestinal diseases. As investors seek promising opportunities..
